Search research articles
Contact Us
Filters
Showing results (41-50 of 51) with videos related to
Page
of 6
Sort By:
International Journal of Molecular Sciences
|
April 14, 2026
<i>miR-122</i> Deficiency in Mice Enhances Regeneration in Healthy Liver but Drives Pathological Repair and Functional Decline in Fibrotic Liver
Jordi Ribera, Anna Cardona-Simó, Irene Portolés, et al.
Cells
|
September 9, 2022
miR-200c-3p, miR-222-5p, and miR-512-3p Constitute a Biomarker Signature of Sorafenib Effectiveness in Advanced Hepatocellular Carcinoma
Patricia de la Cruz-Ojeda, Tobias Schmid, Loreto Boix, et al.
Biomarker Research
|
April 9, 2024
Metallothionein-3 is a multifunctional driver that modulates the development of sorafenib-resistant phenotype in hepatocellular carcinoma cells
Miguel Angel Merlos Rodrigo, Hana Michalkova, Ana Maria Jimenez Jimenez, et al.
Hepatology (Baltimore, Md.)
|
January 22, 2020
Bespoken Nanoceria: An Effective Treatment in Experimental Hepatocellular Carcinoma
Guillermo Fernández-Varo, Meritxell Perramón, Silvia Carvajal, et al.
Medrxiv : the Preprint Server for Health Sciences
|
November 28, 2024
Genome-wide DNA methylation markers associated with metabolic liver cancer
Samuel O Antwi, Ampem Darko Jnr Siaw, Sebastian M Armasu, et al.
Gastro Hep Advances
|
April 25, 2025
Genome-Wide DNA Methylation Markers Associated With Metabolic Liver Cancer
Samuel O Antwi, Ampem Darko Jnr Siaw, Sebastian M Armasu, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
November 29, 2025
Association of Epigenetic Aging Biomarkers With Risk of MASLD-Related HCC
Alani Perkin, Sebastian M Armasu, Winnie Z Fan, et al.
Alimentary Pharmacology & Therapeutics
|
February 23, 2026
Clinical Trial: Early Nivolumab Addition to Regorafenib in Patients With Hepatocellular Carcinoma in Second-Line (The GOING Trial)
Marco Sanduzzi-Zamparelli, Ana Matilla, José Luis Lledo, et al.
Human Molecular Genetics
|
June 27, 2023
Metabolic liver cancer: associations of rare and common germline variants in one-carbon metabolism and DNA methylation genes
Samuel O Antwi, Michael Heckman, Launia White, et al.
Oncotarget
|
February 5, 2015
Stabilization of LKB1 and Akt by neddylation regulates energy metabolism in liver cancer
Lucía Barbier-Torres, Teresa C Delgado, Juan L García-Rodríguez, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 51) with videos related to
Sort By:
Page
of 6
International Journal of Molecular Sciences
|
April 14, 2026
<i>miR-122</i> Deficiency in Mice Enhances Regeneration in Healthy Liver but Drives Pathological Repair and Functional Decline in Fibrotic Liver
Jordi Ribera, Anna Cardona-Simó, Irene Portolés, et al.
Cells
|
September 9, 2022
miR-200c-3p, miR-222-5p, and miR-512-3p Constitute a Biomarker Signature of Sorafenib Effectiveness in Advanced Hepatocellular Carcinoma
Patricia de la Cruz-Ojeda, Tobias Schmid, Loreto Boix, et al.
Biomarker Research
|
April 9, 2024
Metallothionein-3 is a multifunctional driver that modulates the development of sorafenib-resistant phenotype in hepatocellular carcinoma cells
Miguel Angel Merlos Rodrigo, Hana Michalkova, Ana Maria Jimenez Jimenez, et al.
Hepatology (Baltimore, Md.)
|
January 22, 2020
Bespoken Nanoceria: An Effective Treatment in Experimental Hepatocellular Carcinoma
Guillermo Fernández-Varo, Meritxell Perramón, Silvia Carvajal, et al.
Medrxiv : the Preprint Server for Health Sciences
|
November 28, 2024
Genome-wide DNA methylation markers associated with metabolic liver cancer
Samuel O Antwi, Ampem Darko Jnr Siaw, Sebastian M Armasu, et al.
Gastro Hep Advances
|
April 25, 2025
Genome-Wide DNA Methylation Markers Associated With Metabolic Liver Cancer
Samuel O Antwi, Ampem Darko Jnr Siaw, Sebastian M Armasu, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
November 29, 2025
Association of Epigenetic Aging Biomarkers With Risk of MASLD-Related HCC
Alani Perkin, Sebastian M Armasu, Winnie Z Fan, et al.
Alimentary Pharmacology & Therapeutics
|
February 23, 2026
Clinical Trial: Early Nivolumab Addition to Regorafenib in Patients With Hepatocellular Carcinoma in Second-Line (The GOING Trial)
Marco Sanduzzi-Zamparelli, Ana Matilla, José Luis Lledo, et al.
Human Molecular Genetics
|
June 27, 2023
Metabolic liver cancer: associations of rare and common germline variants in one-carbon metabolism and DNA methylation genes
Samuel O Antwi, Michael Heckman, Launia White, et al.
Oncotarget
|
February 5, 2015
Stabilization of LKB1 and Akt by neddylation regulates energy metabolism in liver cancer
Lucía Barbier-Torres, Teresa C Delgado, Juan L García-Rodríguez, et al.
Page
of 6